Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50,495,188
-
Total 13F shares
-
47,238,705
-
Share change
-
+1,021,968
-
Total reported value
-
$5,163,116,710
-
Put/Call ratio
-
35%
-
Price per share
-
$109.45
-
Number of holders
-
338
-
Value change
-
+$107,882,172
-
Number of buys
-
154
-
Number of sells
-
159
Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q4 2017
As of 31 Dec 2017,
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) was held by
338 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,238,705 shares.
The largest 10 holders included
Vanguard Group Inc, BlackRock Inc., FMR LLC, AQR CAPITAL MANAGEMENT LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, ARIEL INVESTMENTS, LLC, STATE STREET CORP, MACKENZIE FINANCIAL CORP, and GOLDMAN SACHS GROUP INC.
This page lists
338
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.